ID

DB08962||

名称

Glibornuride

描述

Glibornuride is a sulfonylurea-type anti-diabetic drug.

cas号

26944-48-9

唯一标识码

VP83E7434R

状态

solid

组

investigational,withdrawn,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as bicyclic monoterpenoids. These are monoterpenoids containing exactly 2 rings, which are fused to each other.
direct-parent:Bicyclic monoterpenoids
kingdom:Organic compounds
superclass:Lipids and lipid-like molecules
class:Prenol lipids
subclass:Monoterpenoids
alternative-parent:Aminosulfonyl compounds
alternative-parent:Aromatic monoterpenoids
alternative-parent:Benzenesulfonamides
alternative-parent:Benzenesulfonyl compounds
alternative-parent:Carbonyl compounds
alternative-parent:Cyclic alcohols and derivatives
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organic carbonic acids and derivatives
alternative-parent:Organic oxides
alternative-parent:Organopnictogen compounds
alternative-parent:Organosulfonic acids and derivatives
alternative-parent:Secondary alcohols
alternative-parent:Sulfonylureas
alternative-parent:Tosyl compounds
substituent:Alcohol
substituent:Aminosulfonyl compound
substituent:Aromatic homopolycyclic compound
substituent:Aromatic monoterpenoid
substituent:Benzenesulfonamide
substituent:Benzenesulfonyl group
substituent:Benzenoid
substituent:Bicyclic monoterpenoid
substituent:Bornane monoterpenoid
substituent:Carbonic acid derivative
substituent:Carbonyl group
substituent:Cyclic alcohol
substituent:Hydrocarbon derivative
substituent:Monocyclic benzene moiety
substituent:Organic nitrogen compound
substituent:Organic oxide
substituent:Organic oxygen compound
substituent:Organic sulfonic acid or derivatives
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Organosulfonic acid or derivatives
substituent:Organosulfur compound
substituent:Secondary alcohol
substituent:Sulfonyl
substituent:Sulfonylurea
substituent:Toluene
substituent:Tosyl compound

消除途径

种类

Alimentary Tract and Metabolism

Blood Glucose Lowering Agents
D007004
Cytochrome P-450 CYP2C9 Substrates

Cytochrome P-450 Substrates

Drugs Used in Diabetes

Sulfones
D013450
Sulfonylureas
D013453
Sulfur Compounds
D013457

盐类

蛋白质结合

清除

同义词

language:german; code:inn; name;Glibornurid
language:spanish; code:inn; name;Glibornurida
language:french; code:inn; name;Glibornuride
language:latin; code:inn; name;Glibornuridum

国际品牌

GlutrilMeda Pharma

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

form:Tablet
route:
strength:25 mg

atc代码

Sulfonylureas
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
DRUGS USED IN DIABETES
ALIMENTARY TRACT AND METABOLISM

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00082
The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glibornuride.
DB04339
The risk or severity of adverse effects can be increased when Glibornuride is combined with Carbocisteine.
DB00446
The metabolism of Glibornuride can be decreased when combined with Chloramphenicol.
DB00501
The serum concentration of Glibornuride can be increased when it is combined with Cimetidine.
DB00196
The serum concentration of Glibornuride can be increased when it is combined with Fluconazole.
DB09046
Metreleptin may increase the hypoglycemic activities of Glibornuride.
DB01032
The protein binding of Glibornuride can be decreased when combined with Probenecid.
DB00863
The serum concentration of Glibornuride can be increased when it is combined with Ranitidine.
DB00582
The serum concentration of Glibornuride can be increased when it is combined with Voriconazole.
DB01211
The serum concentration of Glibornuride can be increased when it is combined with Clarithromycin.
DB00166
The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glibornuride.
DB01045
The serum concentration of Glibornuride can be decreased when it is combined with Rifampicin.
DB00218
The therapeutic efficacy of Glibornuride can be increased when used in combination with Moxifloxacin.
DB00365
The therapeutic efficacy of Glibornuride can be increased when used in combination with Grepafloxacin.
DB00467
The therapeutic efficacy of Glibornuride can be increased when used in combination with Enoxacin.
DB00487
The therapeutic efficacy of Glibornuride can be increased when used in combination with Pefloxacin.
DB00537
The therapeutic efficacy of Glibornuride can be increased when used in combination with Ciprofloxacin.
DB00685
The therapeutic efficacy of Glibornuride can be increased when used in combination with Trovafloxacin.
DB00779
The therapeutic efficacy of Glibornuride can be increased when used in combination with Nalidixic acid.
DB00817
The therapeutic efficacy of Glibornuride can be increased when used in combination with Rosoxacin.
DB00827
The therapeutic efficacy of Glibornuride can be increased when used in combination with Cinoxacin.
DB00978
The therapeutic efficacy of Glibornuride can be increased when used in combination with Lomefloxacin.
DB01044
The therapeutic efficacy of Glibornuride can be increased when used in combination with Gatifloxacin.
DB01059
The therapeutic efficacy of Glibornuride can be increased when used in combination with Norfloxacin.
DB01137
The therapeutic efficacy of Glibornuride can be increased when used in combination with Levofloxacin.
DB01155
The therapeutic efficacy of Glibornuride can be increased when used in combination with Gemifloxacin.
DB01165
The therapeutic efficacy of Glibornuride can be increased when used in combination with Ofloxacin.
DB01208
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sparfloxacin.
DB01405
The therapeutic efficacy of Glibornuride can be increased when used in combination with Temafloxacin.
DB04576
The therapeutic efficacy of Glibornuride can be increased when used in combination with Fleroxacin.
DB05488
The therapeutic efficacy of Glibornuride can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
DB06160
The therapeutic efficacy of Glibornuride can be increased when used in combination with Garenoxacin.
DB06600
The therapeutic efficacy of Glibornuride can be increased when used in combination with Nemonoxacin.
DB08972
The therapeutic efficacy of Glibornuride can be increased when used in combination with Flumequine.
DB11404
The therapeutic efficacy of Glibornuride can be increased when used in combination with Enrofloxacin.
DB11443
The therapeutic efficacy of Glibornuride can be increased when used in combination with Orbifloxacin.
DB11491
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sarafloxacin.
DB11511
The therapeutic efficacy of Glibornuride can be increased when used in combination with Difloxacin.
DB11774
The therapeutic efficacy of Glibornuride can be increased when used in combination with Pazufloxacin.
DB11892
The therapeutic efficacy of Glibornuride can be increased when used in combination with Prulifloxacin.
DB11943
The therapeutic efficacy of Glibornuride can be increased when used in combination with Delafloxacin.
DB13261
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sitafloxacin.
DB13627
The therapeutic efficacy of Glibornuride can be increased when used in combination with Oxolinic acid.
DB13772
The therapeutic efficacy of Glibornuride can be increased when used in combination with Rufloxacin.
DB13823
The therapeutic efficacy of Glibornuride can be increased when used in combination with Pipemidic acid.
DB00232
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methyclothiazide.
DB00310
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlorthalidone.
DB00436
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Bendroflumethiazide.
DB00524
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Metolazone.
DB00562
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Benzthiazide.
DB00774
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydroflumethiazide.
DB00808
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Indapamide.
DB00880
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlorothiazide.
DB00999
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydrochlorothiazide.
DB01021
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Trichlormethiazide.
DB01324
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Polythiazide.
DB01325
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Quinethazone.
DB13532
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Cyclopenthiazide.
DB13989
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Epitizide.
DB00187
Esmolol may increase the hypoglycemic activities of Glibornuride.
DB12212
Landiolol may increase the hypoglycemic activities of Glibornuride.
DB00898
The risk or severity of adverse effects can be increased when Glibornuride is combined with Ethanol.
DB00321
Amitriptyline may decrease the hypoglycemic activities of Glibornuride.
DB00344
Protriptyline may decrease the hypoglycemic activities of Glibornuride.
DB00458
Imipramine may decrease the hypoglycemic activities of Glibornuride.
DB00540
Nortriptyline may decrease the hypoglycemic activities of Glibornuride.
DB00543
Amoxapine may decrease the hypoglycemic activities of Glibornuride.
DB01151
Desipramine may decrease the hypoglycemic activities of Glibornuride.
DB01242
Clomipramine may decrease the hypoglycemic activities of Glibornuride.
DB04836
Amineptine may decrease the hypoglycemic activities of Glibornuride.
DB08996
Dimetacrine may decrease the hypoglycemic activities of Glibornuride.
DB09016
Butriptyline may decrease the hypoglycemic activities of Glibornuride.
DB09167
Dosulepin may decrease the hypoglycemic activities of Glibornuride.
DB09289
Tianeptine may decrease the hypoglycemic activities of Glibornuride.
DB09307
Oxaprotiline may decrease the hypoglycemic activities of Glibornuride.
DB12930
Opipramol may decrease the hypoglycemic activities of Glibornuride.
DB13114
Amitriptylinoxide may decrease the hypoglycemic activities of Glibornuride.
DB13225
Dibenzepin may decrease the hypoglycemic activities of Glibornuride.
DB13246
Quinupramine may decrease the hypoglycemic activities of Glibornuride.
DB13384
Melitracen may decrease the hypoglycemic activities of Glibornuride.
DB13411
Lofepramine may decrease the hypoglycemic activities of Glibornuride.
DB13496
Iprindole may decrease the hypoglycemic activities of Glibornuride.
DB13782
Imipramine oxide may decrease the hypoglycemic activities of Glibornuride.
DB01142
Doxepin may decrease the hypoglycemic activities of Glibornuride.
DB00636
The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glibornuride.
DB01039
The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glibornuride.
DB01393
The risk or severity of hypoglycemia can be increased when Bezafibrate is combined with Glibornuride.
DB08983
The risk or severity of hypoglycemia can be increased when Etofibrate is combined with Glibornuride.
DB09064
The risk or severity of hypoglycemia can be increased when Ciprofibrate is combined with Glibornuride.
DB13433
The risk or severity of hypoglycemia can be increased when Simfibrate is combined with Glibornuride.
DB13460
The risk or severity of hypoglycemia can be increased when Ronifibrate is combined with Glibornuride.
DB13780
The risk or severity of hypoglycemia can be increased when Aluminium clofibrate is combined with Glibornuride.
DB13849
The risk or severity of hypoglycemia can be increased when Clofibride is combined with Glibornuride.
DB13873
The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glibornuride.
DB01110
The serum concentration of Glibornuride can be increased when it is combined with Miconazole.
DB00498
Glibornuride may increase the anticoagulant activities of Phenindione.
DB04665
Glibornuride may increase the anticoagulant activities of Coumarin.
DB08496
Glibornuride may increase the anticoagulant activities of (R)-warfarin.
DB13275
Glibornuride may increase the anticoagulant activities of Clorindione.
DB13347
Glibornuride may increase the anticoagulant activities of Diphenadione.
DB13451
Glibornuride may increase the anticoagulant activities of Tioclomarol.
DB14055
Glibornuride may increase the anticoagulant activities of (S)-Warfarin.
DB00412
The therapeutic efficacy of Glibornuride can be increased when used in combination with Rosiglitazone.
DB01132
The therapeutic efficacy of Glibornuride can be increased when used in combination with Pioglitazone.
DB09199
The therapeutic efficacy of Netoglitazone can be increased when used in combination with Glibornuride.
DB09200
The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Glibornuride.
DB09201
The therapeutic efficacy of Ciglitazone can be increased when used in combination with Glibornuride.
DB12781
The therapeutic efficacy of Balaglitazone can be increased when used in combination with Glibornuride.
DB00197
The therapeutic efficacy of Glibornuride can be increased when used in combination with Troglitazone.
DB09198
The therapeutic efficacy of Glibornuride can be increased when used in combination with Lobeglitazone.
DB01261
Sitagliptin may increase the hypoglycemic activities of Glibornuride.
DB04876
Vildagliptin may increase the hypoglycemic activities of Glibornuride.
DB06011
AMG-222 may increase the hypoglycemic activities of Glibornuride.
DB06127
Bisegliptin may increase the hypoglycemic activities of Glibornuride.
DB06203
Alogliptin may increase the hypoglycemic activities of Glibornuride.
DB06335
Saxagliptin may increase the hypoglycemic activities of Glibornuride.
DB08382
Gosogliptin may increase the hypoglycemic activities of Glibornuride.
DB08882
Linagliptin may increase the hypoglycemic activities of Glibornuride.
DB11723
Dutogliptin may increase the hypoglycemic activities of Glibornuride.
DB11950
Teneligliptin may increase the hypoglycemic activities of Glibornuride.
DB11992
Omarigliptin may increase the hypoglycemic activities of Glibornuride.
DB12268
Carmegliptin may increase the hypoglycemic activities of Glibornuride.
DB12412
Gemigliptin may increase the hypoglycemic activities of Glibornuride.
DB12417
Anagliptin may increase the hypoglycemic activities of Glibornuride.
DB12625
Evogliptin may increase the hypoglycemic activities of Glibornuride.
DB01276
Exenatide may increase the hypoglycemic activities of Glibornuride.
DB06655
Liraglutide may increase the hypoglycemic activities of Glibornuride.
DB09043
Albiglutide may increase the hypoglycemic activities of Glibornuride.
DB09045
Dulaglutide may increase the hypoglycemic activities of Glibornuride.
DB09265
Lixisenatide may increase the hypoglycemic activities of Glibornuride.
DB13928
Semaglutide may increase the hypoglycemic activities of Glibornuride.
DB14027
Taspoglutide may increase the hypoglycemic activities of Glibornuride.
DB06292
Dapagliflozin may increase the hypoglycemic activities of Glibornuride.
DB08907
Canagliflozin may increase the hypoglycemic activities of Glibornuride.
DB00007
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Leuprolide.
DB00014
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Goserelin.
DB00220
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Nelfinavir.
DB00224
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Indinavir.
DB00246
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ziprasidone.
DB00334
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Olanzapine.
DB00363
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Clozapine.
DB00502
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Haloperidol.
DB00503
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ritonavir.
DB00592
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Piperazine.
DB00668
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Epinephrine.
DB00734
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Risperidone.
DB00738
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Pentamidine.
DB00852
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Pseudoephedrine.
DB00864
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Tacrolimus.
DB00877
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Sirolimus.
DB00903
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Etacrynic acid.
DB00932
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Tipranavir.
DB01072
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Atazanavir.
DB01169
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Arsenic trioxide.
DB01224
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Quetiapine.
DB01232
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Saquinavir.
DB01238
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Aripiprazole.
DB01267
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Paliperidone.
DB01319
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Fosamprenavir.
DB01323
The therapeutic efficacy of Glibornuride can be decreased when used in combination with St. John's Wort.
DB01363
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ephedra sinica root.
DB01406
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Danazol.
DB01590
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Everolimus.
DB01601
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Lopinavir.
DB02546
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Vorinostat.
DB04868
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Nilotinib.
DB04946
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Iloperidone.
DB06216
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Asenapine.
DB06287
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Temsirolimus.
DB06663
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Pasireotide.
DB06719
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Buserelin.
DB06788
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Histrelin.
DB06791
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Lanreotide.
DB06825
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Triptorelin.
DB08815
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Lurasidone.
DB09009
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Articaine.
DB09128
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Brexpiprazole.
DB06343
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Teprotumumab.
DB00624
Testosterone may increase the hypoglycemic activities of Glibornuride.
DB00984
Nandrolone phenpropionate may increase the hypoglycemic activities of Glibornuride.
DB01185
Fluoxymesterone may increase the hypoglycemic activities of Glibornuride.
DB01420
Testosterone propionate may increase the hypoglycemic activities of Glibornuride.
DB06412
Oxymetholone may increase the hypoglycemic activities of Glibornuride.
DB06710
Methyltestosterone may increase the hypoglycemic activities of Glibornuride.
DB06718
Stanozolol may increase the hypoglycemic activities of Glibornuride.
DB08804
Nandrolone decanoate may increase the hypoglycemic activities of Glibornuride.
DB12461
GLPG-0492 may increase the hypoglycemic activities of Glibornuride.
DB13169
Nandrolone may increase the hypoglycemic activities of Glibornuride.
DB13587
Mesterolone may increase the hypoglycemic activities of Glibornuride.
DB13943
Testosterone cypionate may increase the hypoglycemic activities of Glibornuride.
DB13946
Testosterone undecanoate may increase the hypoglycemic activities of Glibornuride.
DB00215
The risk or severity of hypoglycemia can be increased when Citalopram is combined with Glibornuride.
DB00230
The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Glibornuride.
DB00285
The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glibornuride.
DB00476
The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Glibornuride.
DB01149
The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Glibornuride.
DB01175
The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Glibornuride.
DB04832
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glibornuride.
DB04884
The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Glibornuride.
DB04896
The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Glibornuride.
DB06700
The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Glibornuride.
DB08918
The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glibornuride.
DB08953
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glibornuride.
DB09270
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glibornuride.
DB12693
The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Glibornuride.
DB13233
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Glibornuride.
DB13358
The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Glibornuride.
DB14025
The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Glibornuride.
DB00233
Aminosalicylic acid may increase the hypoglycemic activities of Glibornuride.
DB00244
Mesalazine may increase the hypoglycemic activities of Glibornuride.
DB00795
Sulfasalazine may increase the hypoglycemic activities of Glibornuride.
DB00861
Diflunisal may increase the hypoglycemic activities of Glibornuride.
DB00936
Salicylic acid may increase the hypoglycemic activities of Glibornuride.
DB01014
Balsalazide may increase the hypoglycemic activities of Glibornuride.
DB01250
Olsalazine may increase the hypoglycemic activities of Glibornuride.
DB01294
Bismuth subsalicylate may increase the hypoglycemic activities of Glibornuride.
DB06251
Dersalazine may increase the hypoglycemic activities of Glibornuride.
DB06807
Phenyl aminosalicylate may increase the hypoglycemic activities of Glibornuride.
DB09543
Methyl salicylate may increase the hypoglycemic activities of Glibornuride.
DB11079
Trolamine salicylate may increase the hypoglycemic activities of Glibornuride.
DB12445
Nitroaspirin may increase the hypoglycemic activities of Glibornuride.
DB13509
Aloxiprin may increase the hypoglycemic activities of Glibornuride.
DB13538
Guacetisal may increase the hypoglycemic activities of Glibornuride.
DB13612
Carbaspirin calcium may increase the hypoglycemic activities of Glibornuride.
DB14006
Choline salicylate may increase the hypoglycemic activities of Glibornuride.
DB14026
Thiosalicylic acid may increase the hypoglycemic activities of Glibornuride.
DB00780
Phenelzine may increase the hypoglycemic activities of Glibornuride.
DB01037
Selegiline may increase the hypoglycemic activities of Glibornuride.
DB01171
Moclobemide may increase the hypoglycemic activities of Glibornuride.
DB01247
Isocarboxazid may increase the hypoglycemic activities of Glibornuride.
DB01367
Rasagiline may increase the hypoglycemic activities of Glibornuride.
DB01626
Pargyline may increase the hypoglycemic activities of Glibornuride.
DB00805
Minaprine may increase the hypoglycemic activities of Glibornuride.
DB04820
Nialamide may increase the hypoglycemic activities of Glibornuride.
DB09244
Pirlindole may increase the hypoglycemic activities of Glibornuride.
DB09245
Toloxatone may increase the hypoglycemic activities of Glibornuride.
DB09243
Hydracarbazine may increase the hypoglycemic activities of Glibornuride.
DB09246
Benmoxin may increase the hypoglycemic activities of Glibornuride.
DB09248
Mebanazine may increase the hypoglycemic activities of Glibornuride.
DB09249
Octamoxin may increase the hypoglycemic activities of Glibornuride.
DB09250
Pheniprazine may increase the hypoglycemic activities of Glibornuride.
DB09251
Phenoxypropazine may increase the hypoglycemic activities of Glibornuride.
DB09252
Pivhydrazine may increase the hypoglycemic activities of Glibornuride.
DB09253
Safrazine may increase the hypoglycemic activities of Glibornuride.
DB09254
Caroxazone may increase the hypoglycemic activities of Glibornuride.
DB00614
Furazolidone may increase the hypoglycemic activities of Glibornuride.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Glibornuride.
DB13875
Harmaline may increase the hypoglycemic activities of Glibornuride.
DB13876
Brofaromine may increase the hypoglycemic activities of Glibornuride.
DB00721
Procaine may increase the hypoglycemic activities of Glibornuride.
DB00182
Amphetamine may increase the hypoglycemic activities of Glibornuride.
DB01168
Procarbazine may increase the hypoglycemic activities of Glibornuride.
DB00601
Linezolid may increase the hypoglycemic activities of Glibornuride.
DB04017
Clorgiline may increase the hypoglycemic activities of Glibornuride.
DB00176
The metabolism of Glibornuride can be decreased when combined with Fluvoxamine.
DB00472
The metabolism of Glibornuride can be decreased when combined with Fluoxetine.
DB00486
The metabolism of Glibornuride can be decreased when combined with Nabilone.
DB00619
The metabolism of Glibornuride can be decreased when combined with Imatinib.
DB00625
The metabolism of Glibornuride can be decreased when combined with Efavirenz.
DB00949
The metabolism of Glibornuride can be decreased when combined with Felbamate.
DB01118
The metabolism of Glibornuride can be decreased when combined with Amiodarone.
DB01138
The metabolism of Glibornuride can be decreased when combined with Sulfinpyrazone.
DB04818
The metabolism of Glibornuride can be decreased when combined with Iproniazid.
DB05812
The metabolism of Glibornuride can be decreased when combined with Abiraterone.
DB14009
The metabolism of Glibornuride can be decreased when combined with Medical Cannabis.
DB00313
The metabolism of Glibornuride can be decreased when combined with Valproic acid.
DB00908
The metabolism of Glibornuride can be decreased when combined with Quinidine.
DB08912
The metabolism of Glibornuride can be increased when combined with Dabrafenib.
DB00322
The metabolism of Glibornuride can be decreased when combined with Floxuridine.
DB00398
The metabolism of Glibornuride can be decreased when combined with Sorafenib.
DB00622
The metabolism of Glibornuride can be decreased when combined with Nicardipine.
DB00705
The metabolism of Glibornuride can be decreased when combined with Delavirdine.
DB01241
The metabolism of Glibornuride can be decreased when combined with Gemfibrozil.
DB06729
The metabolism of Glibornuride can be decreased when combined with Sulfaphenazole.
DB00159
The protein binding of Glibornuride can be decreased when combined with Icosapent.
DB00328
The protein binding of Glibornuride can be decreased when combined with Indomethacin.
DB00461
The protein binding of Glibornuride can be decreased when combined with Nabumetone.
DB00465
The protein binding of Glibornuride can be decreased when combined with Ketorolac.
DB00469
The protein binding of Glibornuride can be decreased when combined with Tenoxicam.
DB00500
The protein binding of Glibornuride can be decreased when combined with Tolmetin.
DB00533
The protein binding of Glibornuride can be decreased when combined with Rofecoxib.
DB00554
The protein binding of Glibornuride can be decreased when combined with Piroxicam.
DB00573
The protein binding of Glibornuride can be decreased when combined with Fenoprofen.
DB00580
The protein binding of Glibornuride can be decreased when combined with Valdecoxib.
DB00586
The protein binding of Glibornuride can be decreased when combined with Diclofenac.
DB00605
The protein binding of Glibornuride can be decreased when combined with Sulindac.
DB00712
The protein binding of Glibornuride can be decreased when combined with Flurbiprofen.
DB00749
The protein binding of Glibornuride can be decreased when combined with Etodolac.
DB00784
The protein binding of Glibornuride can be decreased when combined with Mefenamic acid.
DB00788
The protein binding of Glibornuride can be decreased when combined with Naproxen.
DB00814
The protein binding of Glibornuride can be decreased when combined with Meloxicam.
DB00821
The protein binding of Glibornuride can be decreased when combined with Carprofen.
DB00939
The protein binding of Glibornuride can be decreased when combined with Meclofenamic acid.
DB00991
The protein binding of Glibornuride can be decreased when combined with Oxaprozin.
DB01050
The protein binding of Glibornuride can be decreased when combined with Ibuprofen.
DB01283
The protein binding of Glibornuride can be decreased when combined with Lumiracoxib.
DB01397
The protein binding of Glibornuride can be decreased when combined with Magnesium salicylate.
DB01399
The protein binding of Glibornuride can be decreased when combined with Salsalate.
DB01401
The protein binding of Glibornuride can be decreased when combined with Choline magnesium trisalicylate.
DB01419
The protein binding of Glibornuride can be decreased when combined with Antrafenine.
DB01424
The protein binding of Glibornuride can be decreased when combined with Aminophenazone.
DB01435
The protein binding of Glibornuride can be decreased when combined with Antipyrine.
DB01600
The protein binding of Glibornuride can be decreased when combined with Tiaprofenic acid.
DB02224
The protein binding of Glibornuride can be decreased when combined with Taxifolin.
DB03585
The protein binding of Glibornuride can be decreased when combined with Oxyphenbutazone.
DB04725
The protein binding of Glibornuride can be decreased when combined with Licofelone.
DB04743
The protein binding of Glibornuride can be decreased when combined with Nimesulide.
DB04812
The protein binding of Glibornuride can be decreased when combined with Benoxaprofen.
DB04817
The protein binding of Glibornuride can be decreased when combined with Metamizole.
DB04828
The protein binding of Glibornuride can be decreased when combined with Zomepirac.
DB05095
The protein binding of Glibornuride can be decreased when combined with Cimicoxib.
DB06725
The protein binding of Glibornuride can be decreased when combined with Lornoxicam.
DB06736
The protein binding of Glibornuride can be decreased when combined with Aceclofenac.
DB06737
The protein binding of Glibornuride can be decreased when combined with Zaltoprofen.
DB07402
The protein binding of Glibornuride can be decreased when combined with Azapropazone.
DB08797
The protein binding of Glibornuride can be decreased when combined with Salicylamide.
DB08940
The protein binding of Glibornuride can be decreased when combined with Kebuzone.
DB08942
The protein binding of Glibornuride can be decreased when combined with Isoxicam.
DB08951
The protein binding of Glibornuride can be decreased when combined with Indoprofen.
DB08955
The protein binding of Glibornuride can be decreased when combined with Ibuproxam.
DB08976
The protein binding of Glibornuride can be decreased when combined with Floctafenine.
DB08981
The protein binding of Glibornuride can be decreased when combined with Fenbufen.
DB08984
The protein binding of Glibornuride can be decreased when combined with Etofenamate.
DB08991
The protein binding of Glibornuride can be decreased when combined with Epirizole.
DB09084
The protein binding of Glibornuride can be decreased when combined with Benzydamine.
DB09213
The protein binding of Glibornuride can be decreased when combined with Dexibuprofen.
DB09214
The protein binding of Glibornuride can be decreased when combined with Dexketoprofen.
DB09215
The protein binding of Glibornuride can be decreased when combined with Droxicam.
DB09216
The protein binding of Glibornuride can be decreased when combined with Tolfenamic acid.
DB09217
The protein binding of Glibornuride can be decreased when combined with Firocoxib.
DB09218
The protein binding of Glibornuride can be decreased when combined with Clonixin.
DB09285
The protein binding of Glibornuride can be decreased when combined with Morniflumate.
DB09288
The protein binding of Glibornuride can be decreased when combined with Propacetamol.
DB09295
The protein binding of Glibornuride can be decreased when combined with Talniflumate.
DB11455
The protein binding of Glibornuride can be decreased when combined with Robenacoxib.
DB11466
The protein binding of Glibornuride can be decreased when combined with Tepoxalin.
DB11518
The protein binding of Glibornuride can be decreased when combined with Flunixin.
DB12399
The protein binding of Glibornuride can be decreased when combined with Polmacoxib.
DB12545
The protein binding of Glibornuride can be decreased when combined with Indobufen.
DB12610
The protein binding of Glibornuride can be decreased when combined with Ebselen.
DB13001
The protein binding of Glibornuride can be decreased when combined with Tinoridine.
DB13167
The protein binding of Glibornuride can be decreased when combined with Alclofenac.
DB13217
The protein binding of Glibornuride can be decreased when combined with Fentiazac.
DB13232
The protein binding of Glibornuride can be decreased when combined with Suxibuzone.
DB13286
The protein binding of Glibornuride can be decreased when combined with Bumadizone.
DB13314
The protein binding of Glibornuride can be decreased when combined with Alminoprofen.
DB13371
The protein binding of Glibornuride can be decreased when combined with Difenpiramide.
DB13407
The protein binding of Glibornuride can be decreased when combined with Nifenazone.
DB13432
The protein binding of Glibornuride can be decreased when combined with Lonazolac.
DB13481
The protein binding of Glibornuride can be decreased when combined with Tenidap.
DB13524
The protein binding of Glibornuride can be decreased when combined with Propyphenazone.
DB13527
The protein binding of Glibornuride can be decreased when combined with Proglumetacin.
DB13544
The protein binding of Glibornuride can be decreased when combined with Ethenzamide.
DB13629
The protein binding of Glibornuride can be decreased when combined with Mofebutazone.
DB13649
The protein binding of Glibornuride can be decreased when combined with Proquazone.
DB13657
The protein binding of Glibornuride can be decreased when combined with Benorilate.
DB13722
The protein binding of Glibornuride can be decreased when combined with Pirprofen.
DB13783
The protein binding of Glibornuride can be decreased when combined with Acemetacin.
DB13860
The protein binding of Glibornuride can be decreased when combined with Imidazole salicylate.
DB14059
The protein binding of Glibornuride can be decreased when combined with SC-236.
DB14060
The protein binding of Glibornuride can be decreased when combined with NS-398.
DB14938
The protein binding of Glibornuride can be decreased when combined with Flurbiprofen axetil.
DB01009
The protein binding of Glibornuride can be decreased when combined with Ketoprofen.
DB08439
The protein binding of Glibornuride can be decreased when combined with Parecoxib.
DB09212
The protein binding of Glibornuride can be decreased when combined with Loxoprofen.
DB11827
The therapeutic efficacy of Glibornuride can be increased when used in combination with Ertugliflozin.
DB00214
The therapeutic efficacy of Glibornuride can be increased when used in combination with Torasemide.
DB00263
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfisoxazole.
DB00311
The therapeutic efficacy of Glibornuride can be increased when used in combination with Ethoxzolamide.
DB00359
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadiazine.
DB00482
The therapeutic efficacy of Glibornuride can be increased when used in combination with Celecoxib.
DB00576
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamethizole.
DB00606
The therapeutic efficacy of Glibornuride can be increased when used in combination with Cyclothiazide.
DB00664
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfametopyrazine.
DB00669
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sumatriptan.
DB00695
The therapeutic efficacy of Glibornuride can be increased when used in combination with Furosemide.
DB00706
The therapeutic efficacy of Glibornuride can be increased when used in combination with Tamsulosin.
DB00819
The therapeutic efficacy of Glibornuride can be increased when used in combination with Acetazolamide.
DB00887
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bumetanide.
DB00891
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfapyridine.
DB00909
The therapeutic efficacy of Glibornuride can be increased when used in combination with Zonisamide.
DB01015
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamethoxazole.
DB01098
The therapeutic efficacy of Glibornuride can be increased when used in combination with Rosuvastatin.
DB01119
The therapeutic efficacy of Glibornuride can be increased when used in combination with Diazoxide.
DB01144
The therapeutic efficacy of Glibornuride can be increased when used in combination with Diclofenamide.
DB01264
The therapeutic efficacy of Glibornuride can be increased when used in combination with Darunavir.
DB01298
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfacytine.
DB01299
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadoxine.
DB01382
The therapeutic efficacy of Glibornuride can be increased when used in combination with Glymidine.
DB01581
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamerazine.
DB01582
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamethazine.
DB02925
The therapeutic efficacy of Glibornuride can be increased when used in combination with Piretanide.
DB04707
The therapeutic efficacy of Glibornuride can be increased when used in combination with Hydroxyfasudil.
DB06150
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadimethoxine.
DB06290
The therapeutic efficacy of Glibornuride can be increased when used in combination with Simeprevir.
DB06821
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfameter.
DB07996
The therapeutic efficacy of Glibornuride can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.
DB08162
The therapeutic efficacy of Glibornuride can be increased when used in combination with Fasudil.
DB08798
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamoxole.
DB08961
The therapeutic efficacy of Glibornuride can be increased when used in combination with Azosemide.
DB11389
The therapeutic efficacy of Glibornuride can be increased when used in combination with Clorsulon.
DB11461
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfachlorpyridazine.
DB11462
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaethoxypyridazine.
DB11463
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfanitran.
DB11464
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaquinoxaline.
DB12051
The therapeutic efficacy of Glibornuride can be increased when used in combination with Setrobuvir.
DB12921
The therapeutic efficacy of Glibornuride can be increased when used in combination with Chlorsulfaquinoxaline.
DB13214
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadicramide.
DB13248
The therapeutic efficacy of Glibornuride can be increased when used in combination with Phthalylsulfathiazole.
DB13283
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaisodimidine.
DB13284
The therapeutic efficacy of Glibornuride can be increased when used in combination with Meticrane.
DB13320
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaperin.
DB13405
The therapeutic efficacy of Glibornuride can be increased when used in combination with Mefruside.
DB13430
The therapeutic efficacy of Glibornuride can be increased when used in combination with Mebutizide.
DB13485
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfametomidine.
DB13547
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfatolamide.
DB13556
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamazone.
DB13580
The therapeutic efficacy of Glibornuride can be increased when used in combination with Succinylsulfathiazole.
DB13617
The therapeutic efficacy of Glibornuride can be increased when used in combination with Clorexolone.
DB13663
The therapeutic efficacy of Glibornuride can be increased when used in combination with Clofenamide.
DB13699
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfathiourea.
DB13708
The therapeutic efficacy of Glibornuride can be increased when used in combination with Fenquizone.
DB13726
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaguanidine.
DB13773
The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfamethoxypyridazine.
DB13792
The therapeutic efficacy of Glibornuride can be increased when used in combination with Clopamide.
DB13803
The therapeutic efficacy of Glibornuride can be increased when used in combination with Xipamide.
DB14033
The therapeutic efficacy of Glibornuride can be increased when used in combination with Acetyl sulfisoxazole.
DB06370
The therapeutic efficacy of Glibornuride can be increased when used in combination with Indisulam.
DB00703
The therapeutic efficacy of Glibornuride can be increased when used in combination with Methazolamide.
DB00559
The metabolism of Glibornuride can be increased when combined with Bosentan.
DB08899
The metabolism of Glibornuride can be increased when combined with Enzalutamide.
DB00022
The metabolism of Glibornuride can be increased when combined with Peginterferon alfa-2b.
DB11901
The metabolism of Glibornuride can be increased when combined with Apalutamide.
DB11995
The metabolism of Glibornuride can be increased when combined with Avatrombopag.
DB00177
The metabolism of Glibornuride can be decreased when combined with Valsartan.
DB00227
The metabolism of Glibornuride can be decreased when combined with Lovastatin.
DB00238
The metabolism of Glibornuride can be decreased when combined with Nevirapine.
DB00317
The metabolism of Glibornuride can be decreased when combined with Gefitinib.
DB00323
The metabolism of Glibornuride can be decreased when combined with Tolcapone.
DB00439
The metabolism of Glibornuride can be decreased when combined with Cerivastatin.
DB00444
The metabolism of Glibornuride can be decreased when combined with Teniposide.
DB00448
The metabolism of Glibornuride can be decreased when combined with Lansoprazole.
DB00515
The metabolism of Glibornuride can be decreased when combined with Cisplatin.
DB00544
The metabolism of Glibornuride can be decreased when combined with Fluorouracil.
DB00549
The metabolism of Glibornuride can be decreased when combined with Zafirlukast.
DB00613
The metabolism of Glibornuride can be decreased when combined with Amodiaquine.
DB00621
The metabolism of Glibornuride can be decreased when combined with Oxandrolone.
DB00641
The metabolism of Glibornuride can be decreased when combined with Simvastatin.
DB00665
The metabolism of Glibornuride can be decreased when combined with Nilutamide.
DB00715
The metabolism of Glibornuride can be decreased when combined with Paroxetine.
DB00745
The metabolism of Glibornuride can be decreased when combined with Modafinil.
DB00752
The metabolism of Glibornuride can be decreased when combined with Tranylcypromine.
DB00758
The metabolism of Glibornuride can be decreased when combined with Clopidogrel.
DB00812
The metabolism of Glibornuride can be decreased when combined with Phenylbutazone.
DB00916
The metabolism of Glibornuride can be decreased when combined with Metronidazole.
DB00951
The metabolism of Glibornuride can be decreased when combined with Isoniazid.
DB01016
The metabolism of Glibornuride can be decreased when combined with Glyburide.
DB01023
The metabolism of Glibornuride can be decreased when combined with Felodipine.
DB01095
The metabolism of Glibornuride can be decreased when combined with Fluvastatin.
DB01097
The metabolism of Glibornuride can be decreased when combined with Leflunomide.
DB01104
The metabolism of Glibornuride can be decreased when combined with Sertraline.
DB01117
The metabolism of Glibornuride can be decreased when combined with Atovaquone.
DB01128
The metabolism of Glibornuride can be decreased when combined with Bicalutamide.
DB01129
The metabolism of Glibornuride can be decreased when combined with Rabeprazole.
DB01176
The metabolism of Glibornuride can be decreased when combined with Cyclizine.
DB01195
The metabolism of Glibornuride can be decreased when combined with Flecainide.
DB01381
The metabolism of Glibornuride can be decreased when combined with Ginkgo biloba.
DB01411
The metabolism of Glibornuride can be decreased when combined with Pranlukast.
DB01628
The metabolism of Glibornuride can be decreased when combined with Etoricoxib.
DB01645
The metabolism of Glibornuride can be decreased when combined with Genistein.
DB01685
The metabolism of Glibornuride can be decreased when combined with Topiroxostat.
DB03756
The metabolism of Glibornuride can be decreased when combined with Doconexent.
DB04920
The metabolism of Glibornuride can be decreased when combined with Clevidipine.
DB06174
The metabolism of Glibornuride can be decreased when combined with Noscapine.
DB06268
The metabolism of Glibornuride can be decreased when combined with Sitaxentan.
DB06413
The metabolism of Glibornuride can be decreased when combined with Armodafinil.
DB06414
The metabolism of Glibornuride can be decreased when combined with Etravirine.
DB06442
The metabolism of Glibornuride can be decreased when combined with Avasimibe.
DB06594
The metabolism of Glibornuride can be decreased when combined with Agomelatine.
DB06595
The metabolism of Glibornuride can be decreased when combined with Midostaurin.
DB06654
The metabolism of Glibornuride can be decreased when combined with Safinamide.
DB06731
The metabolism of Glibornuride can be decreased when combined with Seproxetine.
DB08828
The metabolism of Glibornuride can be decreased when combined with Vismodegib.
DB08881
The metabolism of Glibornuride can be decreased when combined with Vemurafenib.
DB09063
The metabolism of Glibornuride can be decreased when combined with Ceritinib.
DB09078
The metabolism of Glibornuride can be decreased when combined with Lenvatinib.
DB09118
The metabolism of Glibornuride can be decreased when combined with Stiripentol.
DB09238
The metabolism of Glibornuride can be decreased when combined with Manidipine.
DB11633
The metabolism of Glibornuride can be decreased when combined with Isavuconazole.
DB11753
The metabolism of Glibornuride can be decreased when combined with Rifamycin.
DB11994
The metabolism of Glibornuride can be decreased when combined with Diacerein.
DB12245
The metabolism of Glibornuride can be decreased when combined with Triclabendazole.
DB12319
The metabolism of Glibornuride can be decreased when combined with Benzbromarone.
DB12332
The metabolism of Glibornuride can be decreased when combined with Rucaparib.
DB13975
The metabolism of Glibornuride can be decreased when combined with Black cohosh.
DB00673
The metabolism of Glibornuride can be decreased when combined with Aprepitant.
DB00604
The metabolism of Glibornuride can be decreased when combined with Cisapride.
DB04831
The metabolism of Glibornuride can be decreased when combined with Tienilic acid.
DB04856
The metabolism of Glibornuride can be decreased when combined with Dexloxiglumide.
DB14635
The metabolism of Glibornuride can be decreased when combined with Curcumin sulfate.
DB08896
The metabolism of Glibornuride can be decreased when combined with Regorafenib.
DB09280
The metabolism of Glibornuride can be decreased when combined with Lumacaftor.
DB15822
The metabolism of Glibornuride can be decreased when combined with Pralsetinib.
DB00208
The metabolism of Glibornuride can be decreased when combined with Ticlopidine.
DB04911
The metabolism of Glibornuride can be decreased when combined with Oritavancin.
DB08816
The metabolism of Glibornuride can be decreased when combined with Ticagrelor.
DB13174
The metabolism of Glibornuride can be decreased when combined with Rhein.
DB13919
The metabolism of Glibornuride can be decreased when combined with Candesartan.
DB00203
The metabolism of Glibornuride can be decreased when combined with Sildenafil.
DB00184
The metabolism of Glibornuride can be decreased when combined with Nicotine.
DB00216
The metabolism of Glibornuride can be decreased when combined with Eletriptan.
DB00250
The metabolism of Glibornuride can be decreased when combined with Dapsone.
DB00307
The metabolism of Glibornuride can be decreased when combined with Bexarotene.
DB00327
The metabolism of Glibornuride can be decreased when combined with Hydromorphone.
DB00333
The metabolism of Glibornuride can be decreased when combined with Methadone.
DB00338
The metabolism of Glibornuride can be decreased when combined with Omeprazole.
DB00374
The metabolism of Glibornuride can be decreased when combined with Treprostinil.
DB00425
The metabolism of Glibornuride can be decreased when combined with Zolpidem.
DB00440
The metabolism of Glibornuride can be decreased when combined with Trimethoprim.
DB00470
The metabolism of Glibornuride can be decreased when combined with Dronabinol.
DB00471
The metabolism of Glibornuride can be decreased when combined with Montelukast.
DB00495
The metabolism of Glibornuride can be decreased when combined with Zidovudine.
DB00514
The metabolism of Glibornuride can be decreased when combined with Dextromethorphan.
DB00532
The metabolism of Glibornuride can be decreased when combined with Mephenytoin.
DB00590
The metabolism of Glibornuride can be decreased when combined with Doxazosin.
DB00617
The metabolism of Glibornuride can be decreased when combined with Paramethadione.
DB00678
The metabolism of Glibornuride can be decreased when combined with Losartan.
DB00701
The metabolism of Glibornuride can be decreased when combined with Amprenavir.
DB00744
The metabolism of Glibornuride can be decreased when combined with Zileuton.
DB00755
The metabolism of Glibornuride can be decreased when combined with Tretinoin.
DB00794
The metabolism of Glibornuride can be decreased when combined with Primidone.
DB00796
The metabolism of Glibornuride can be decreased when combined with Candesartan cilexetil.
DB00818
The metabolism of Glibornuride can be decreased when combined with Propofol.
DB00829
The metabolism of Glibornuride can be decreased when combined with Diazepam.
DB00843
The metabolism of Glibornuride can be decreased when combined with Donepezil.
DB00857
The metabolism of Glibornuride can be decreased when combined with Terbinafine.
DB00904
The metabolism of Glibornuride can be decreased when combined with Ondansetron.
DB00921
The metabolism of Glibornuride can be decreased when combined with Buprenorphine.
DB00969
The metabolism of Glibornuride can be decreased when combined with Alosetron.
DB00980
The metabolism of Glibornuride can be decreased when combined with Ramelteon.
DB00983
The metabolism of Glibornuride can be decreased when combined with Formoterol.
DB01028
The metabolism of Glibornuride can be decreased when combined with Methoxyflurane.
DB01029
The metabolism of Glibornuride can be decreased when combined with Irbesartan.
DB01036
The metabolism of Glibornuride can be decreased when combined with Tolterodine.
DB01041
The metabolism of Glibornuride can be decreased when combined with Thalidomide.
DB01065
The metabolism of Glibornuride can be decreased when combined with Melatonin.
DB01075
The metabolism of Glibornuride can be decreased when combined with Diphenhydramine.
DB01131
The metabolism of Glibornuride can be decreased when combined with Proguanil.
DB01154
The metabolism of Glibornuride can be decreased when combined with Thiamylal.
DB01156
The metabolism of Glibornuride can be decreased when combined with Bupropion.
DB01159
The metabolism of Glibornuride can be decreased when combined with Halothane.
DB01177
The metabolism of Glibornuride can be decreased when combined with Idarubicin.
DB01181
The metabolism of Glibornuride can be decreased when combined with Ifosfamide.
DB01198
The metabolism of Glibornuride can be decreased when combined with Zopiclone.
DB01221
The metabolism of Glibornuride can be decreased when combined with Ketamine.
DB01274
The metabolism of Glibornuride can be decreased when combined with Arformoterol.
DB01355
The metabolism of Glibornuride can be decreased when combined with Hexobarbital.
DB01544
The metabolism of Glibornuride can be decreased when combined with Flunitrazepam.
DB01589
The metabolism of Glibornuride can be decreased when combined with Quazepam.
DB03783
The metabolism of Glibornuride can be decreased when combined with Phenacetin.
DB04557
The metabolism of Glibornuride can be decreased when combined with Arachidonic Acid.
DB04898
The metabolism of Glibornuride can be decreased when combined with Ximelagatran.
DB04938
The metabolism of Glibornuride can be decreased when combined with Ospemifene.
DB05541
The metabolism of Glibornuride can be decreased when combined with Brivaracetam.
DB06204
The metabolism of Glibornuride can be decreased when combined with Tapentadol.
DB06209
The metabolism of Glibornuride can be decreased when combined with Prasugrel.
DB06218
The metabolism of Glibornuride can be decreased when combined with Lacosamide.
DB06605
The metabolism of Glibornuride can be decreased when combined with Apixaban.
DB06652
The metabolism of Glibornuride can be decreased when combined with Vicriviroc.
DB06697
The metabolism of Glibornuride can be decreased when combined with Artemether.
DB06738
The metabolism of Glibornuride can be decreased when combined with Ketobemidone.
DB06739
The metabolism of Glibornuride can be decreased when combined with Seratrodast.
DB06803
The metabolism of Glibornuride can be decreased when combined with Niclosamide.
DB08860
The metabolism of Glibornuride can be decreased when combined with Pitavastatin.
DB09048
The metabolism of Netupitant can be decreased when combined with Glibornuride.
DB09061
The metabolism of Cannabidiol can be decreased when combined with Glibornuride.
DB09068
The metabolism of Vortioxetine can be decreased when combined with Glibornuride.
DB09080
The metabolism of Olodaterol can be decreased when combined with Glibornuride.
DB11560
The metabolism of Lesinurad can be decreased when combined with Glibornuride.
DB11586
The metabolism of Asunaprevir can be decreased when combined with Glibornuride.
DB11614
The metabolism of Rupatadine can be decreased when combined with Glibornuride.
DB11823
The metabolism of Esketamine can be decreased when combined with Glibornuride.
DB13941
The metabolism of Piperaquine can be decreased when combined with Glibornuride.
DB13955
The metabolism of Estradiol dienanthate can be decreased when combined with Glibornuride.
DB14011
The metabolism of Nabiximols can be decreased when combined with Glibornuride.
DB11757
The metabolism of Istradefylline can be decreased when combined with Glibornuride.
DB14975
The metabolism of Voxelotor can be decreased when combined with Glibornuride.
DB00972
The metabolism of Glibornuride can be decreased when combined with Azelastine.
DB15233
The metabolism of Avapritinib can be decreased when combined with Glibornuride.
DB11689
The metabolism of Selumetinib can be decreased when combined with Glibornuride.
DB00188
The metabolism of Glibornuride can be decreased when combined with Bortezomib.
DB06448
The metabolism of Glibornuride can be decreased when combined with Lonafarnib.
DB00726
The metabolism of Glibornuride can be decreased when combined with Trimipramine.
DB01101
The metabolism of Glibornuride can be decreased when combined with Capecitabine.
DB00675
The metabolism of Glibornuride can be decreased when combined with Tamoxifen.
DB13874
The metabolism of Glibornuride can be decreased when combined with Enasidenib.
DB00531
The metabolism of Glibornuride can be decreased when combined with Cyclophosphamide.
DB01174
The metabolism of Glibornuride can be decreased when combined with Phenobarbital.
DB05109
The metabolism of Glibornuride can be decreased when combined with Trabectedin.
DB08875
The metabolism of Glibornuride can be decreased when combined with Cabozantinib.
DB11963
The metabolism of Dacomitinib can be decreased when combined with Glibornuride.
DB12147
The metabolism of Erdafitinib can be decreased when combined with Glibornuride.
DB13136
The metabolism of Fluindione can be decreased when combined with Glibornuride.
DB12371
The metabolism of Siponimod can be decreased when combined with Glibornuride.
DB00030
The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glibornuride.
DB00046
The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glibornuride.
DB00047
The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glibornuride.
DB00071
The risk or severity of hypoglycemia can be increased when Insulin pork is combined with Glibornuride.
DB00222
The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glibornuride.
DB00280
The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Glibornuride.
DB00284
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Glibornuride.
DB00331
The risk or severity of hypoglycemia can be increased when Metformin is combined with Glibornuride.
DB00414
The risk or severity of hypoglycemia can be increased when Acetohexamide is combined with Glibornuride.
DB00468
The risk or severity of hypoglycemia can be increased when Quinine is combined with Glibornuride.
DB00491
The risk or severity of hypoglycemia can be increased when Miglitol is combined with Glibornuride.
DB00672
The risk or severity of hypoglycemia can be increased when Chlorpropamide is combined with Glibornuride.
DB00731
The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Glibornuride.
DB00839
The risk or severity of hypoglycemia can be increased when Tolazamide is combined with Glibornuride.
DB00912
The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Glibornuride.
DB00914
The risk or severity of hypoglycemia can be increased when Phenformin is combined with Glibornuride.
DB01067
The risk or severity of hypoglycemia can be increased when Glipizide is combined with Glibornuride.
DB01120
The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Glibornuride.
DB01124
The risk or severity of hypoglycemia can be increased when Tolbutamide is combined with Glibornuride.
DB01200
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Glibornuride.
DB01251
The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Glibornuride.
DB01252
The risk or severity of hypoglycemia can be increased when Mitiglinide is combined with Glibornuride.
DB01268
The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Glibornuride.
DB01277
The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Glibornuride.
DB01278
The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Glibornuride.
DB01289
The risk or severity of hypoglycemia can be increased when Glisoxepide is combined with Glibornuride.
DB01306
The risk or severity of hypoglycemia can be increased when Insulin aspart is combined with Glibornuride.
DB01307
The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Glibornuride.
DB01309
The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Glibornuride.
DB01700
The risk or severity of hypoglycemia can be increased when AICA ribonucleotide is combined with Glibornuride.
DB04830
The risk or severity of hypoglycemia can be increased when Buformin is combined with Glibornuride.
DB04878
The risk or severity of hypoglycemia can be increased when Voglibose is combined with Glibornuride.
DB05115
The risk or severity of hypoglycemia can be increased when NN344 is combined with Glibornuride.
DB05819
The risk or severity of hypoglycemia can be increased when NBI-6024 is combined with Glibornuride.
DB09022
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Benfluorex.
DB09456
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Insulin beef.
DB09564
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Insulin degludec.
DB11567
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Insulin peglispro.
DB11568
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Insulin tregopil.
DB11698
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Ipragliflozin.
DB11780
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Allicin.
DB11824
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Tofogliflozin.
DB11898
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with 2,4-thiazolidinedione.
DB12713
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Sotagliflozin.
DB12935
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Remogliflozin etabonate.
DB13406
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Carbutamide.
DB13446
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Guar gum.
DB13675
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Metahexamide.
DB14035
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Englitazone.
DB15171
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Tirzepatide.
DB15217
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Gastric inhibitory polypeptide.
DB09038
The risk or severity of hypoglycemia can be increased when Glibornuride is combined with Empagliflozin.
DB00270
The risk or severity of hypoglycemia can be increased when Isradipine is combined with Glibornuride.
DB00381
The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glibornuride.
DB00393
The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glibornuride.
DB00401
The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glibornuride.
DB00528
The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Glibornuride.
DB00555
The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Glibornuride.
DB00593
The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Glibornuride.
DB00653
The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Glibornuride.
DB00836
The risk or severity of hypoglycemia can be increased when Loperamide is combined with Glibornuride.
DB01054
The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Glibornuride.
DB01074
The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Glibornuride.
DB01244
The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glibornuride.
DB01388
The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Glibornuride.
DB04825
The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Glibornuride.
DB04838
The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Glibornuride.
DB04842
The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Glibornuride.
DB05246
The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Glibornuride.
DB05885
The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glibornuride.
DB06152
The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glibornuride.
DB06283
The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glibornuride.
DB06446
The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Glibornuride.
DB06694
The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glibornuride.
DB06712
The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Glibornuride.
DB07615
The risk or severity of hypoglycemia can be increased when Tranilast is combined with Glibornuride.
DB08838
The risk or severity of hypoglycemia can be increased when Agmatine is combined with Glibornuride.
DB08980
The risk or severity of hypoglycemia can be increased when Fendiline is combined with Glibornuride.
DB08992
The risk or severity of hypoglycemia can be increased when Eperisone is combined with Glibornuride.
DB09089
The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Glibornuride.
DB09090
The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Glibornuride.
DB09227
The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Glibornuride.
DB09229
The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Glibornuride.
DB09230
The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Glibornuride.
DB09231
The risk or severity of hypoglycemia can be increased when Benidipine is combined with Glibornuride.
DB09232
The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Glibornuride.
DB09234
The risk or severity of hypoglycemia can be increased when Darodipine is combined with Glibornuride.
DB09235
The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Glibornuride.
DB09236
The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Glibornuride.
DB09239
The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Glibornuride.
DB09240
The risk or severity of hypoglycemia can be increased when Niludipine is combined with Glibornuride.
DB11960
The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Glibornuride.
DB12092
The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Glibornuride.
DB12093
The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Glibornuride.
DB12131
The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Glibornuride.
DB12923
The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Glibornuride.
DB13488
The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Glibornuride.
DB13500
The risk or severity of hypoglycemia can be increased when Otilonium is combined with Glibornuride.
DB13725
The risk or severity of hypoglycemia can be increased when Terodiline is combined with Glibornuride.
DB13766
The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Glibornuride.
DB13791
The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Glibornuride.
DB13835
The risk or severity of hypoglycemia can be increased when Caroverine is combined with Glibornuride.
DB13950
The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Glibornuride.
DB13961
The risk or severity of hypoglycemia can be increased when Fish oil is combined with Glibornuride.
DB14063
The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Glibornuride.
DB14064
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Glibornuride.
DB14065
The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Glibornuride.
DB14066
The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Glibornuride.
DB14068
The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Glibornuride.
DB00343
The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Glibornuride.
DB00347
The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Glibornuride.
DB00568
The risk or severity of hypoglycemia can be increased when Cinnarizine is combined with Glibornuride.
DB04841
The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Glibornuride.
DB00661
The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glibornuride.
DB01115
The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Glibornuride.
DB00005
The metabolism of Glibornuride can be increased when combined with Etanercept.
DB00026
The metabolism of Glibornuride can be increased when combined with Anakinra.
DB00051
The metabolism of Glibornuride can be increased when combined with Adalimumab.
DB00065
The metabolism of Glibornuride can be increased when combined with Infliximab.
DB01281
The metabolism of Glibornuride can be increased when combined with Abatacept.
DB04956
The metabolism of Glibornuride can be increased when combined with Afelimomab.
DB05676
The metabolism of Glibornuride can be increased when combined with Apremilast.
DB06168
The metabolism of Glibornuride can be increased when combined with Canakinumab.
DB06273
The metabolism of Glibornuride can be increased when combined with Tocilizumab.
DB06372
The metabolism of Glibornuride can be increased when combined with Rilonacept.
DB06674
The metabolism of Glibornuride can be increased when combined with Golimumab.
DB08904
The metabolism of Glibornuride can be increased when combined with Certolizumab pegol.
DB09029
The metabolism of Glibornuride can be increased when combined with Secukinumab.
DB09036
The metabolism of Glibornuride can be increased when combined with Siltuximab.
DB14724
The metabolism of Glibornuride can be increased when combined with Emapalumab.
DB00191
The therapeutic efficacy of Glibornuride can be increased when used in combination with Phentermine.
DB00279
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Liothyronine.
DB00542
The risk or severity of hypoglycemia can be increased when Benazepril is combined with Glibornuride.
DB00945
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Glibornuride.
DB00181
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Baclofen.
DB00489
The risk or severity of hypoglycemia can be increased when Sotalol is combined with Glibornuride.
DB12015
The serum concentration of Glibornuride can be decreased when it is combined with Alpelisib.
DB00195
The therapeutic efficacy of Glibornuride can be increased when used in combination with Betaxolol.
DB00264
The therapeutic efficacy of Glibornuride can be increased when used in combination with Metoprolol.
DB00335
The therapeutic efficacy of Glibornuride can be increased when used in combination with Atenolol.
DB00373
The therapeutic efficacy of Glibornuride can be increased when used in combination with Timolol.
DB00571
The therapeutic efficacy of Glibornuride can be increased when used in combination with Propranolol.
DB00598
The therapeutic efficacy of Glibornuride can be increased when used in combination with Labetalol.
DB00612
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bisoprolol.
DB00866
The therapeutic efficacy of Glibornuride can be increased when used in combination with Alprenolol.
DB00960
The therapeutic efficacy of Glibornuride can be increased when used in combination with Pindolol.
DB01136
The therapeutic efficacy of Glibornuride can be increased when used in combination with Carvedilol.
DB01182
The therapeutic efficacy of Glibornuride can be increased when used in combination with Propafenone.
DB01193
The therapeutic efficacy of Glibornuride can be increased when used in combination with Acebutolol.
DB01203
The therapeutic efficacy of Glibornuride can be increased when used in combination with Nadolol.
DB01295
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bevantolol.
DB01297
The therapeutic efficacy of Glibornuride can be increased when used in combination with Practolol.
DB01359
The therapeutic efficacy of Glibornuride can be increased when used in combination with Penbutolol.
DB01580
The therapeutic efficacy of Glibornuride can be increased when used in combination with Oxprenolol.
DB03322
The therapeutic efficacy of Glibornuride can be increased when used in combination with Dexpropranolol.
DB04846
The therapeutic efficacy of Glibornuride can be increased when used in combination with Celiprolol.
DB04861
The therapeutic efficacy of Glibornuride can be increased when used in combination with Nebivolol.
DB06726
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bufuralol.
DB08807
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bopindolol.
DB08808
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bupranolol.
DB08952
The therapeutic efficacy of Glibornuride can be increased when used in combination with Indenolol.
DB09204
The therapeutic efficacy of Glibornuride can be increased when used in combination with Arotinolol.
DB09351
The therapeutic efficacy of Glibornuride can be increased when used in combination with Levobetaxolol.
DB11770
The therapeutic efficacy of Glibornuride can be increased when used in combination with Talinolol.
DB11785
The therapeutic efficacy of Glibornuride can be increased when used in combination with Anisodamine.
DB12752
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bucindolol.
DB13443
The therapeutic efficacy of Glibornuride can be increased when used in combination with Esatenolol.
DB13508
The therapeutic efficacy of Glibornuride can be increased when used in combination with Cloranolol.
DB13530
The therapeutic efficacy of Glibornuride can be increased when used in combination with Mepindolol.
DB13757
The therapeutic efficacy of Glibornuride can be increased when used in combination with Epanolol.
DB13775
The therapeutic efficacy of Glibornuride can be increased when used in combination with Tertatolol.
DB01611
The therapeutic efficacy of Glibornuride can be increased when used in combination with Hydroxychloroquine.
DB00682
The therapeutic efficacy of Warfarin can be increased when used in combination with Glibornuride.
DB03410
The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glibornuride.
DB08794
The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Glibornuride.
DB00266
The therapeutic efficacy of Dicoumarol can be increased when used in combination with Glibornuride.
DB00946
The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Glibornuride.
DB01418
The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Glibornuride.
DB01051
The therapeutic efficacy of Glibornuride can be increased when used in combination with Novobiocin.
DB03966
The therapeutic efficacy of Glibornuride can be increased when used in combination with Clorobiocin.
DB04571
The therapeutic efficacy of Glibornuride can be increased when used in combination with Trioxsalen.
DB04886
The therapeutic efficacy of Glibornuride can be increased when used in combination with Calanolide A.
DB07118
The therapeutic efficacy of Glibornuride can be increased when used in combination with Hymecromone.
DB11390
The therapeutic efficacy of Glibornuride can be increased when used in combination with Coumaphos.
DB11419
The therapeutic efficacy of Glibornuride can be increased when used in combination with Haloxon.
DB12216
The therapeutic efficacy of Glibornuride can be increased when used in combination with Bergapten.
DB12823
The therapeutic efficacy of Glibornuride can be increased when used in combination with Tecarfarin.
DB13155
The therapeutic efficacy of Glibornuride can be increased when used in combination with Esculin.
DB13177
The therapeutic efficacy of Glibornuride can be increased when used in combination with 4-methylumbelliferyl beta-D-glucoside.
DB13279
The therapeutic efficacy of Glibornuride can be increased when used in combination with Carbocromen.
DB13367
The therapeutic efficacy of Glibornuride can be increased when used in combination with Cloricromen.
DB13912
The therapeutic efficacy of Glibornuride can be increased when used in combination with Coumermycin A1.
DB00477
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlorpromazine.
DB01403
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methotrimeprazine.
DB01621
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Pipotiazine.
DB09241
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methylene blue.
DB01069
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Promethazine.
DB00420
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Promazine.
DB00372
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Thiethylperazine.
DB00433
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Prochlorperazine.
DB00508
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Triflupromazine.
DB00623
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Fluphenazine.
DB00679
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Thioridazine.
DB00680
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Moricizine.
DB00831
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Trifluoperazine.
DB00850
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Perphenazine.
DB00933
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Mesoridazine.
DB01063
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Acetophenazine.
DB01246
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Alimemazine.
DB01608
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Periciazine.
DB01614
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Acepromazine.
DB01615
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Aceprometazine.
DB01622
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Thioproperazine.
DB05687
The therapeutic efficacy of Glibornuride can be decreased when used in combination with BL-1020.
DB09000
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Cyamemazine.
DB11540
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Propiopromazine.
DB12710
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Perazine.
DB13213
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Butaperazine.
DB13382
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlorproethazine.
DB13420
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Thiazinam.
DB13784
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Dixyrazine.
DB14651
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Perphenazine enanthate.
DB00763
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methimazole.
DB00017
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Salmon calcitonin.
DB00066
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Follitropin.
DB00389
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Carbimazole.
DB00550
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Propylthiouracil.
DB03374
The therapeutic efficacy of Glibornuride can be decreased when used in combination with 3,5-Diiodotyrosine.
DB05084
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Abaloparatide.
DB05829
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Parathyroid hormone.
DB06285
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Teriparatide.
DB06715
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Potassium Iodide.
DB07637
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Dibromotyrosine.
DB09418
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Potassium perchlorate.
DB09421
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Protirelin.
DB12629
The therapeutic efficacy of Glibornuride can be decreased when used in combination with 3,5-diiodothyropropionic acid.
DB13644
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methylthiouracil.
DB13742
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Elcatonin.
DB13804
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Benzylthiouracil.
DB15263
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Thyrotropin.
DB00783
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estradiol.
DB00977
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ethinylestradiol.
DB01357
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Mestranol.
DB04574
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estrone sulfate.
DB00255
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Diethylstilbestrol.
DB13952
The therapeutic efficacy of Estradiol acetate can be decreased when used in combination with Glibornuride.
DB13953
The therapeutic efficacy of Estradiol benzoate can be decreased when used in combination with Glibornuride.
DB13954
The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Glibornuride.
DB13956
The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Glibornuride.
DB00269
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlorotrianisene.
DB00286
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Conjugated estrogens.
DB00655
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estrone.
DB00890
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Dienestrol.
DB04573
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estriol.
DB04575
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Quinestrol.
DB07931
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hexestrol.
DB09070
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Tibolone.
DB09317
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Synthetic Conjugated Estrogens, A.
DB09318
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Synthetic Conjugated Estrogens, B.
DB09369
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Polyestradiol phosphate.
DB09381
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Esterified estrogens.
DB11478
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Zeranol.
DB11674
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Equol.
DB12487
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Promestriene.
DB13143
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Methallenestril.
DB13386
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Epimestrol.
DB13418
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Moxestrol.
DB15334
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Biochanin A.
DB15335
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Formononetin.
DB00294
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Etonogestrel.
DB00304
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Desogestrel.
DB00351
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Megestrol acetate.
DB00367
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Levonorgestrel.
DB00396
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Progesterone.
DB00603
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Medroxyprogesterone acetate.
DB00717
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norethisterone.
DB00823
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ethynodiol diacetate.
DB00957
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norgestimate.
DB01395
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Drospirenone.
DB04839
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Cyproterone acetate.
DB06789
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydroxyprogesterone caproate.
DB09123
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Dienogest.
DB13944
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Testosterone enanthate.
DB00834
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Mifepristone.
DB12474
The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Glibornuride.
DB04066
The therapeutic efficacy of Glibornuride can be decreased when used in combination with p-Coumaric acid.
DB04682
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
DB05830
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Trestolone.
DB06266
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Lonidamine.
DB06713
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norelgestromin.
DB06730
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Gestodene.
DB06804
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Nonoxynol-9.
DB08867
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ulipristal.
DB09371
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norethynodrel.
DB09389
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norgestrel.
DB09401
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Isosorbide.
DB11507
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Cloprostenol.
DB11619
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Gestrinone.
DB11636
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Nomegestrol.
DB12025
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Triptolide.
DB13044
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Gossypol.
DB13310
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Ormeloxifene.
DB13528
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Chlormadinone.
DB13563
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norgestrienone.
DB13685
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Quingestanol.
DB13857
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Demegestone.
DB13866
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Etynodiol.
DB13981
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Nomegestrol acetate.
DB14583
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Segesterone acetate.
DB14678
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Norethindrone enanthate.
DB00252
The therapeutic efficacy of Phenytoin can be decreased when used in combination with Glibornuride.
DB01320
The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Glibornuride.
DB00627
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Niacin.
DB00394
The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Glibornuride.
DB00443
The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Glibornuride.
DB00620
The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Glibornuride.
DB00635
The risk or severity of hyperglycemia can be increased when Prednisone is combined with Glibornuride.
DB00687
The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Glibornuride.
DB00741
The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glibornuride.
DB00764
The risk or severity of hyperglycemia can be increased when Mometasone is combined with Glibornuride.
DB00860
The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Glibornuride.
DB00959
The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Glibornuride.
DB01234
The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glibornuride.
DB01285
The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glibornuride.
DB01380
The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Glibornuride.
DB01384
The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Glibornuride.
DB01410
The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Glibornuride.
DB08906
The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glibornuride.
DB08970
The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glibornuride.
DB08971
The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glibornuride.
DB09383
The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Glibornuride.
DB11487
The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Glibornuride.
DB11750
The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Glibornuride.
DB11921
The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Glibornuride.
DB13003
The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Glibornuride.
DB13208
The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Glibornuride.
DB13843
The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Glibornuride.
DB13867
The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Glibornuride.
DB14512
The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Glibornuride.
DB00180
The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Glibornuride.
DB01108
The risk or severity of hyperglycemia can be increased when Trilostane is combined with Glibornuride.
DB01222
The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glibornuride.
DB04630
The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Glibornuride.
DB09378
The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Glibornuride.
DB11529
The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Glibornuride.
DB14681
The risk or severity of hyperglycemia can be increased when Cortisone is combined with Glibornuride.
DB00223
The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Glibornuride.
DB00240
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Glibornuride.
DB00253
The risk or severity of hyperglycemia can be increased when Medrysone is combined with Glibornuride.
DB00288
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Glibornuride.
DB00324
The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Glibornuride.
DB00547
The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Glibornuride.
DB00588
The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Glibornuride.
DB00591
The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Glibornuride.
DB00596
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glibornuride.
DB00663
The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Glibornuride.
DB00838
The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Glibornuride.
DB00846
The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Glibornuride.
DB00896
The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Glibornuride.
DB01013
The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Glibornuride.
DB01047
The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Glibornuride.
DB01130
The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Glibornuride.
DB01260
The risk or severity of hyperglycemia can be increased when Desonide is combined with Glibornuride.
DB06781
The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Glibornuride.
DB06786
The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glibornuride.
DB09091
The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Glibornuride.
DB09095
The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Glibornuride.
DB13158
The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Glibornuride.
DB13223
The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Glibornuride.
DB13491
The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Glibornuride.
DB13664
The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glibornuride.
DB13728
The risk or severity of hyperglycemia can be increased when Halometasone is combined with Glibornuride.
DB13856
The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Glibornuride.
DB14538
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Glibornuride.
DB14539
The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glibornuride.
DB14540
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glibornuride.
DB14541
The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glibornuride.
DB14543
The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glibornuride.
DB14544
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glibornuride.
DB14545
The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glibornuride.
DB00873
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Glibornuride.
DB14631
The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Glibornuride.
DB14633
The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Glibornuride.
DB14634
The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Glibornuride.
DB14643
The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Glibornuride.
DB14644
The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Glibornuride.
DB14646
The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Glibornuride.
DB14652
The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Glibornuride.
DB14659
The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Glibornuride.
DB14669
The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Glibornuride.
DB15566
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Glibornuride.
DB00451
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Levothyroxine.
DB00024
Thyrotropin alfa may decrease the hypoglycemic activities of Glibornuride.
DB01583
Liotrix may decrease the hypoglycemic activities of Glibornuride.
DB03604
Tiratricol may decrease the hypoglycemic activities of Glibornuride.
DB09100
Thyroid, porcine may decrease the hypoglycemic activities of Glibornuride.
DB00104
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Octreotide.
DB15762
The serum concentration of Glibornuride can be decreased when it is combined with Satralizumab.
DB15093
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Somapacitan.

序列

实验性质

Melting Point
193-195
U.S. Patent 3,654,357.

外部标识符

resource：ChEBI
identifier：135545
resource：PubChem Compound
identifier：12818200
resource：PubChem Substance
identifier：310264926
resource：KEGG Drug
identifier：D02427
resource：ChemSpider
identifier：16735831
resource：Wikipedia
identifier：Glibornuride
resource：ChEMBL
identifier：CHEMBL529888
resource：ZINC
identifier：ZINC000002012812
resource：RxCUI
identifier：102846

外部链接

Drugs.com
http://www.drugs.com/international/Glibornuride.html

路径

目标

酶

BE0002793Cytochrome P450 2C9HumanssubstrateunknownCytochrome P450 2C9Steroid hydroxylase activityCytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.CYP2C910q24Endoplasmic reticulum membrane7.9955627.36510HumansHUGO Gene Nomenclature Committee (HGNC)HGNC:2623GenAtlasCYP2C9GenBank Gene DatabaseAY341248Guide to Pharmacology1326UniProtKBP11712UniProt AccessionCP2C9_HUMAN(R)-limonene 6-monooxygenase(S)-limonene 6-monooxygenase(S)-limonene 7-monooxygenase1.14.13.-Cholesterol 25-hydroxylaseCYP2C10CYPIIC9Cytochrome P-450MPCytochrome P450 MP-4Cytochrome P450 MP-8Cytochrome P450 PB-1S-mephenytoin 4-hydroxylase>lcl|BSEQ0005471|Cytochrome P450 2C9 MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV YGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS IIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM KSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID LLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK KSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP PFYQLCFIPV>lcl|BSEQ0016893|Cytochrome P450 2C9 (CYP2C9) ATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG AGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA AATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC TATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT GAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC CCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG AAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC ATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG GCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC ATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG TTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT CCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG AAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT CAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT GAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG ACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA GCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA GACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC CTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC ATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA TTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG AAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG GCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT CTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG CCCTTCTACCAGCTGTGCTTCATTCCTGTCTGAPF00067p450componentcytoplasmcomponentendoplasmic reticulum membranecomponentintracellular membrane-bounded organellefunction(R)-limonene 6-monooxygenase activityfunction(S)-limonene 6-monooxygenase activityfunction(S)-limonene 7-monooxygenase activityfunctionarachidonic acid epoxygenase activityfunctionaromatase activityfunctioncaffeine oxidase activityfunctiondrug bindingfunctionheme bindingfunctioniron ion bindingfunctionmonooxygenase activityfunctionoxidoreductase activityfunctionoxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenfunctionoxygen bindingfunctionsteroid hydroxylase activityprocessarachidonic acid metabolic processprocesscellular amide metabolic processprocessdrug catabolic processprocessdrug metabolic processprocessepoxygenase P450 pathwayprocessexogenous drug catabolic processprocessmonocarboxylic acid metabolic processprocessmonoterpenoid metabolic processprocessomega-hydroxylase P450 pathwayprocessoxidation-reduction processprocessoxidative demethylationprocesssmall molecule metabolic processprocesssteroid metabolic processprocessurea metabolic processprocessxenobiotic metabolic process

载体

运输工具

药物反应

效应

不良反应